| |
|
| OMX COPENHAGEN 20 |
|
| Kepler Cheuvreux |
|
| Pharma & Biotech |
|
| 3.17 /5 |
|
| 63.33 % |
|
| 26.89 % |
|
| 1ère ANALYSE |
|
| NOVO NORDISK (livre danois DKK) |
|
| 05/09/2014 |
|
| 258 DKK |
|
| 300 DKK |
|
| 16.3 % |
|
| BUY |
|
| 316.2 DKK |
|
| 22.56 % |
|
| OMX COPENHAGEN 20 |
|
| 742.17 DKK |
|
| 875.43 DKK |
|
| 17.96 % |
|
| 369.5 DKK |
|
| 250.2 DKK |
|
| 1 /1 |
|
| 1 /1 |
|
| 4 /4 |
|
| 2 /2 |
|
| 0 /2 |
|
| 43.22 % |
|
| 27.55 % |
|
| Oui |
|
| 2e ANALYSE |
|
| NOVOZYMES (livre danois) |
|
| 05/09/2014 |
|
| 265.6 DKK |
|
| 220 DKK |
|
| -17.2 % |
|
| REDUCE |
|
| 319 DKK |
|
| 20.11 % |
|
| OMX COPENHAGEN 20 |
|
| 742.17 DKK |
|
| 875.43 DKK |
|
| 17.96 % |
|
| 289.7 DKK |
|
| 245.9 DKK |
|
| 0 /1 |
|
| 0 /1 |
|
| 0 /4 |
|
| 0 /2 |
|
| 1 /2 |
|
| 9.07 % |
|
| 27.55 % |
|
| Non |
|
| 3e ANALYSE |
|
| CHR.HANSEN (livre danois) |
|
| 05/09/2014 |
|
| 233.5 DKK |
|
| 260 DKK |
|
| 11.3 % |
|
| BUY |
|
| 301.75 DKK |
|
| 29 % |
|
| OMX COPENHAGEN 20 |
|
| 742.17 DKK |
|
| 875.43 DKK |
|
| 17.96 % |
|
| 342.13 DKK |
|
| 403.13 DKK |
|
| 1 /1 |
|
| 1 /1 |
|
| 4 /4 |
|
| 2 /2 |
|
| 2 /2 |
|
| 46.52 % |
|
| 27.55 % |
|
| Oui |